Long-term quality-of-life outcomes following prostate radiotherapy with or without high-dose-rate brachytherapy boost: post-hoc analysis of TROG 03.04 RADAR

By sjmartinez • October 7, 2023

Ong WL, Nikitas J, Joseph D, Steigler A, Millar J, Valle L, Steinberg ML, Martin T, Reiter RE, Rettig MB, Nickols NG, Chang A, Zaorsky NG, Spratt DE, Romero T, Kishan AU. Long-term quality-of-life outcomes following prostate radiotherapy with or without high-dose-rate brachytherapy boost: post-hoc analysis of TROG 03.04 RADAR. Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07972-5. doi: 10.1016/j.ijrobp.2023.09.051. Epub ahead of print. PMID: 37802226.

Tags: General Internal Medicine, Hematology/Oncology, Publications, Veterans Administration

Related Posts

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia[...]

Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes: a prospective cohort study

Nguyen XT, Li Y, Czernichow S, Rassy N, Houghton SC, Lu B, Ho YL, Charest BR, Wang DD, Gagnon DR, Gaziano JM, Willett WC, Wilson[...]

Discontinuation of statins by patient and physician sex: An observational study

Watanabe A, Miyamoto Y, Ueyama HA, Gotanda H, Slipczuk L, Inoue K, Secemsky E, Laham R, Bhatt DL, Tsugawa Y, Kuno T. Discontinuation of statins[...]